Supplementary Tables 1-3 from Activation of the mTOR Pathway in Primary Medullary Thyroid Carcinoma and Lymph Node Metastases

PDF file - 138K, Table S1. Characteristics of 53 MTC (hereditary or sporadic) cases for which the RAS/MEK/ERK and PI3K/AKT/mTOR pathways were studied; Table S2. Study of MTC samples for RET and RAS mutation status and for immunoreactivity for pS6, pAKT and Perk; Table S3. Antibodies used for immunohistochemistry